Development of SV2A Ligands for Epilepsy Treatment: A Review of Levetiracetam, Brivaracetam, and Padsevonil
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Development of SV2A Ligands for Epilepsy Treatment: A Review of Levetiracetam, Brivaracetam, and Padsevonil
Authors
Keywords
-
Journal
Neuroscience Bulletin
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-10-28
DOI
10.1007/s12264-023-01138-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Presynaptic targeting of botulinum neurotoxin type A requires a tripartite PSG‐Syt1‐SV2 plasma membrane nanocluster for synaptic vesicle entry
- (2023) Merja Joensuu et al. EMBO JOURNAL
- Structural basis for botulinum neurotoxin E recognition of synaptic vesicle protein 2
- (2023) Zheng Liu et al. Nature Communications
- A Practical Guide to the Treatment of Dravet Syndrome with Anti-Seizure Medication
- (2022) Adam Strzelczyk et al. CNS DRUGS
- Expression profile of synaptic vesicle glycoprotein 2A, B, and C paralogues in temporal neocortex tissue from patients with temporal lobe epilepsy (TLE)
- (2022) Burcu A. Pazarlar et al. Molecular Brain
- Synaptic Vesicle Glycoprotein 2A: Features and Functions
- (2022) Rachele Rossi et al. Frontiers in Neuroscience
- Neuroimaging in schizophrenia: an overview of findings and their implications for synaptic changes
- (2022) Oliver D. Howes et al. NEUROPSYCHOPHARMACOLOGY
- Efficacy and safety of adjunctive padsevonil in adults with drug‐resistant focal epilepsy: Results from two double‐blind, randomized, placebo‐controlled trials
- (2022) Michael Rademacher et al. Epilepsia Open
- An update on brivaracetam for the treatment of pediatric partial epilepsy
- (2021) Eleonora Tulli et al. EXPERT OPINION ON PHARMACOTHERAPY
- Levetiracetam for Seizure Prophylaxis in Neurocritical Care: A Systematic Review and Meta-analysis
- (2021) Taolin Fang et al. Neurocritical Care
- Functional characterization of the antiepileptic drug candidate, padsevonil, on GABA A receptors
- (2020) Isabelle Niespodziany et al. EPILEPSIA
- An epilepsy-associated SV2A mutation disrupts synaptotagmin-1 expression and activity-dependent trafficking
- (2020) Callista B. Harper et al. JOURNAL OF NEUROSCIENCE
- Mechanisms of action of currently used antiseizure drugs
- (2020) Graeme J. Sills et al. NEUROPHARMACOLOGY
- Clinical experience with brivaracetam in a series of 46 children
- (2020) Núria Visa-Reñé et al. EPILEPSY & BEHAVIOR
- Drug Resistance in Epilepsy: Clinical Impact, Potential Mechanisms, and New Innovative Treatment Options
- (2020) Wolfgang Löscher et al. PHARMACOLOGICAL REVIEWS
- Impact of predictive, preventive and precision medicine strategies in epilepsy
- (2020) Rima Nabbout et al. Nature Reviews Neurology
- Synaptic vesicle protein 2: A multi-faceted regulator of secretion
- (2019) Kristine Ciruelas et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Epilepsy in adults
- (2019) Roland D Thijs et al. LANCET
- Safety and Tolerability of Adjunctive Brivaracetam in Pediatric Patients
- (2019) Edwin Liu et al. PEDIATRIC DRUGS
- The Synaptic Vesicle Glycoprotein 2: Structure, Function, and Disease Relevance
- (2019) Kristen A. Stout et al. ACS Chemical Neuroscience
- Safety and Efficacy of Brivaracetam in Pediatric Refractory Epilepsy: A Single-Center Clinical Experience
- (2019) Sara McGuire et al. JOURNAL OF CHILD NEUROLOGY
- Pharmacological Profile of the Novel Antiepileptic Drug Candidate Padsevonil: Characterization in Rodent Seizure and Epilepsy Models
- (2019) Karine Leclercq et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Pharmacological Profile of the Novel Antiepileptic Drug Candidate Padsevonil: Interactions with Synaptic Vesicle 2 Proteins and the GABAA Receptor
- (2019) Martyn Wood et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Treatment with brivaracetam in children – The experience of a pediatric epilepsy center
- (2019) Andreea Nissenkorn et al. EPILEPSY & BEHAVIOR
- Levetiracetam
- (2018) Paul Howard et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- Epilepsy
- (2018) Orrin Devinsky et al. Nature Reviews Disease Primers
- Progress report on new antiepileptic drugs: A summary of the Fourteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIV). II. Drugs in more advanced clinical development
- (2018) Meir Bialer et al. EPILEPSIA
- Acute and long-term effects of brivaracetam and brivaracetam-diazepam combinations in an experimental model of status epilepticus
- (2017) Jerome Niquet et al. EPILEPSIA
- Efficacy and safety of antiepileptic drugs for refractory partial-onset epilepsy: a network meta-analysis
- (2017) Qingting Hu et al. JOURNAL OF NEUROLOGY
- Synaptic Vesicle-Recycling Machinery Components as Potential Therapeutic Targets
- (2017) Ying C. Li et al. PHARMACOLOGICAL REVIEWS
- New developments in the management of partial-onset epilepsy: role of brivaracetam
- (2017) Giangennaro Coppola et al. Drug Design Development and Therapy
- Brivaracetam: a novel antiepileptic drug for focal-onset seizures
- (2017) Linda J. Stephen et al. Therapeutic Advances in Neurological Disorders
- A New SV2A Ligand for Epilepsy
- (2016) Michael A. Rogawski CELL
- Synaptic Vesicle Glycoprotein 2A Ligands in the Treatment of Epilepsy and Beyond
- (2016) Wolfgang Löscher et al. CNS DRUGS
- Brivaracetam: Rationale for discovery and preclinical profile of a selective SV2A ligand for epilepsy treatment
- (2016) Henrik Klitgaard et al. EPILEPSIA
- Brivaracetam add-on for refractory focal epilepsy
- (2016) Simona Lattanzi et al. NEUROLOGY
- Activation-induced regulation of GABAA receptors: Is there a link with the molecular basis of benzodiazepine tolerance?
- (2016) María Clara Gravielle PHARMACOLOGICAL RESEARCH
- Mechanisms of Action of Antiseizure Drugs and the Ketogenic Diet
- (2016) Michael A. Rogawski et al. Cold Spring Harbor Perspectives in Medicine
- Brivaracetam in Unverricht-Lundborg disease (EPM1): Results from two randomized, double-blind, placebo-controlled studies
- (2015) Reetta Kälviäinen et al. EPILEPSIA
- Levetiracetam accelerates the onset of supply rate depression in synaptic vesicle trafficking
- (2015) Elizabeth García-Pérez et al. EPILEPSIA
- A randomized, double-blind, placebo-controlled, multicenter, parallel-group study to evaluate the efficacy and safety of adjunctive brivaracetam in adult patients with uncontrolled partial-onset seizures
- (2015) Pavel Klein et al. EPILEPSIA
- Brivaracetam augments short-term depression and slows vesicle recycling
- (2015) Xiaofeng Yang et al. EPILEPSIA
- Brivaracetam, a selective high-affinity synaptic vesicle protein 2A (SV2A) ligand with preclinical evidence of high brain permeability and fast onset of action
- (2015) Jean-Marie Nicolas et al. EPILEPSIA
- Phosphorylation of Synaptic Vesicle Protein 2A at Thr84 by Casein Kinase 1 Family Kinases Controls the Specific Retrieval of Synaptotagmin-1
- (2015) N. Zhang et al. JOURNAL OF NEUROSCIENCE
- Brivaracetam Differentially Affects Voltage-Gated Sodium Currents Without Impairing Sustained Repetitive Firing in Neurons
- (2014) Isabelle Niespodziany et al. CNS Neuroscience & Therapeutics
- Synaptic vesicle glycoprotein 2A modulates vesicular release and calcium channel function at peripheral sympathetic synapses
- (2014) Christian Vogl et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- The Human Synaptic Vesicle Protein, SV2A, Functions as a Galactose Transporter inSaccharomyces cerevisiae
- (2014) Marianna Madeo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: A phase III randomized, double-blind, placebo-controlled trial
- (2013) Victor Biton et al. EPILEPSIA
- Adjunctive brivaracetam for uncontrolled focal and generalized epilepsies: Results of a phase III, double-blind, randomized, placebo-controlled, flexible-dose trial
- (2013) Patrick Kwan et al. EPILEPSIA
- Adjunctive brivaracetam in adults with uncontrolled focal epilepsy: Results from a double-blind, randomized, placebo-controlled trial
- (2013) Philippe Ryvlin et al. EPILEPSIA
- Inhibition of Ca2+-regulated exocytosis by levetiracetam, a ligand for SV2A, in antral mucous cells of guinea pigs
- (2013) Saeko Harada et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Brivaracetam Disposition in Mild to Severe Hepatic Impairment
- (2013) Armel Stockis et al. JOURNAL OF CLINICAL PHARMACOLOGY
- New avenues for anti-epileptic drug discovery and development
- (2013) Wolfgang Löscher et al. NATURE REVIEWS DRUG DISCOVERY
- Levetiracetam Use in the Critical Care Setting
- (2013) Jennifer L. DeWolfe et al. Frontiers in Neurology
- Efficacy and tolerability of adjunctive brivaracetam in adults with uncontrolled partial-onset seizures: A phase IIb, randomized, controlled trial
- (2012) Wim Van Paesschen et al. EPILEPSIA
- Brivaracetam Disposition in Renal Impairment
- (2012) Maria Laura Sargentini-Maier et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Pegloticase
- (2011) Katherine A. Lyseng-Williamson DRUGS
- Binding characteristics of brivaracetam, a selective, high affinity SV2A ligand in rat, mouse and human brain: Relationship to anti-convulsant properties
- (2011) Michel Gillard et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- A new mechanism for antiepileptic drug action: vesicular entry may mediate the effects of levetiracetam
- (2011) Anna L. Meehan et al. JOURNAL OF NEUROPHYSIOLOGY
- Levetiracetam Reverses Synaptic Deficits Produced by Overexpression of SV2A
- (2011) Amy Nowack et al. PLoS One
- Levetiracetam suppresses development of spontaneous EEG seizures and aberrant neurogenesis following kainate-induced status epilepticus
- (2010) Yuki Sugaya et al. BRAIN RESEARCH
- Levetiracetam: The Preclinical Profile of a New Class of Antiepileptic Drugs?
- (2010) Henrik Klitgaard EPILEPSIA
- Efficacy and safety of levetiracetam as adjunctive therapy in adult patients with uncontrolled partial epilepsy: The Asia SKATE II Study
- (2010) Patrick Kwan et al. EPILEPSY & BEHAVIOR
- Cotrafficking of SV2 and Synaptotagmin at the Synapse
- (2010) J. Yao et al. JOURNAL OF NEUROSCIENCE
- Adjunctive brivaracetam for refractory partial-onset seizures: A randomized, controlled trial
- (2010) J. A. French et al. NEUROLOGY
- 11-Deoxycortisol impedes GABAergic neurotransmission and induces drug-resistant status epilepticus in mice
- (2010) Rafal M. Kaminski et al. NEUROPHARMACOLOGY
- SV2 Mediates Entry of Tetanus Neurotoxin into Central Neurons
- (2010) Felix L. Yeh et al. PLoS Pathogens
- Synaptotagmin-Mediated Bending of the Target Membrane Is a Critical Step in Ca2+-Regulated Fusion
- (2009) Enfu Hui et al. CELL
- Adjunctive levetiracetam in infants and young children with refractory partial-onset seizures
- (2009) Jesus Eric Piña-Garza et al. EPILEPSIA
- Proepileptic phenotype of SV2A-deficient mice is associated with reduced anticonvulsant efficacy of levetiracetam
- (2009) Rafal M. Kaminski et al. EPILEPSIA
- Brivaracetam (ucb 34714) inhibits Na+ current in rat cortical neurons in culture
- (2009) Cristina Zona et al. EPILEPSY RESEARCH
- SV2 Renders Primed Synaptic Vesicles Competent for Ca2+-Induced Exocytosis
- (2009) W.-P. Chang et al. JOURNAL OF NEUROSCIENCE
- Levetiracetam has a time- and stimulation-dependent effect on synaptic transmission
- (2009) Xiao-Feng Yang et al. SEIZURE-EUROPEAN JOURNAL OF EPILEPSY
- Effects of chronic treatment with levetiracetam on hippocampal field responses after pilocarpine-induced status epilepticus in rats
- (2008) Doru-Georg Margineanu et al. BRAIN RESEARCH BULLETIN
- The pharmacokinetics, CNS pharmacodynamics and adverse event profile of brivaracetam after multiple increasing oral doses in healthy men
- (2008) Paul Rolan et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Brivaracetam: a rational drug discovery success story
- (2008) M A Rogawski BRITISH JOURNAL OF PHARMACOLOGY
- Anti-convulsive and anti-epileptic properties of brivaracetam (ucb 34714), a high-affinity ligand for the synaptic vesicle protein, SV2A
- (2008) A Matagne et al. BRITISH JOURNAL OF PHARMACOLOGY
- Pharmacological Management of Epilepsy
- (2008) Cecilie Johannessen Landmark et al. DRUGS
- Anticonvulsive and antiepileptogenic effects of levetiracetam in the audiogenic kindling model
- (2008) Lyudmila V. Vinogradova et al. EPILEPSIA
- Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in Chinese patients with refractory partial-onset seizures
- (2008) Xun-Yi Wu et al. EPILEPSIA
- Brivaracetam: a new drug in development for epilepsy and neuropathic pain
- (2008) Barbara Malawska et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures
- (2008) S. Noachtar et al. NEUROLOGY
- Fragment-Based Approach to Drug??Lead Discovery
- (2008) Daniela Fattori et al. Drugs in research & development
- SV2A protein is a broad-spectrum anticonvulsant target: Functional correlation between protein binding and seizure protection in models of both partial and generalized epilepsy
- (2007) Rafal M. Kaminski et al. NEUROPHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started